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Regional ventricular wall mutton analysis utilizing three different
methods was performed on predisekarge left ventricotograms
from 291 of 367 patients enrolled in a randomized trial of single
'balm recombinant tissne-dype plarmfnogen activator (rl •PA),
mplrln and heparln with and without Immediate ongtoplasty in
patients with acute uyorardiet infaretin .v
With Imivariate analysis, no difference in regional wall motion
variables between the two treatment groups was observed . How.
ever, with individual baseline risk assessment by multivariate
linear regression analysis using baseline
characteristics
known to
he related to left vetnrleular function after thrmbolytc therapy
or outcome of cmanary angioplasty . or both, an excess or high risk
patients in the invasive treatment group was detected . To adjust
for this unequal distribution or baseline risk, multivariate linear
In 1988, the European Cooperative Study Group II) put,
lisped the results of a trial comparing an invasive strategy,
combining thrombolysis wiih recombinant tissue-type plas-
minogen activator (re-PA), heparin, aspirin and immediate
coronary angioplasty, with a noninvasive strategy of intra-
venous et-PA, heparin and aspirin in patients with acute
myocardial infarction . Contrary to expectations when the
trial was initiated, the invasive treatment strategy did not
result in smaller enzymaie infarct size, better global left
ventricular function and lower mortality rate . In fact. com-
plications were more frequent and the mortality rate was
higher after the invasive strategy I 11 .
Additional analyses were performed m e, alaate whether:
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regression analysis was performed- No benefit of immediate
coronary, angioplasty was observed after adjustment .
Reocctusion or reinfaretiou, or both, occurred mare frequently
is the invasive than in The naoainrdSire heatnsent group (11%
versus 11%, respeelively) . Among patients wilh a patent israrct-
related vessel on angiograply between days 10 and 22 and without
reinfarctton before aogirgraphy, there wasa (rend woard benefit
from the ianasire strategy, indicating that reoculvaial and rein-
faeetioa might be respwsible for the lack of benefit of the deasix
cerategy. This Implies that Immediate coronary angioplasty any
be henefieial in mitered patients, provided that their rmplin •
lions can be prevented.
fl Am
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I I a true benefit of immediate angioplasty was not detected
because of an excess of high risk patients in the invasive
treatment group, despite mndnmiration ; 21 a true benefit in
one subgroup was obscured by an adverse effect in another .
which would have important implications if these subgroups
could he identified on admission or if they would be charac-
tcrir :d by an adverse event like reocclusion or reinfarctinn,
which may be prevented by new treatment strategies : and 3)
preservation of function in the infarct territory was missed
by using global function as the variable because of compen-
satory hyperkinesia of the contralateral wall (2) .
The results of these investigations are presented to this
report . Multivariate analysis was used to adjust for unequal
baseline risk and assess treatment effects in subgroups of
patients. Regional left ventricular wall motion analysis in the
infarct Iemtory was performed to evaluate the role of
compensatory hyperkinesia of the noninfarcted area .
Methods
Study patients
. of 347 patients <71 years of age with
a30 min of chest pain and electrocardiographic (ECG)
evidence of extensive transmural myocardial ischemia . 184
D7a5.t~91/rhsa
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Table 1 .
Reasons for Missing Angiography netween nays Ia to 22
for .Analysis of Regional Wall Motion
were allocated to noninvasive treatment and 183 to immedi-
ate angiography and coronary angioplasty, provided that
thrombolytic therapy could be started within 5 h after onset
of symptoms, Patients with a previous myocardial infarction
at the same site or with previous coronary artery bypass
surgery were excluded, but patients with heart failure or
shock were not . Further details of patient selection have
been published elsewhere (I). Left ventricular angiography
of adequate quality for analysis was available in 291 patients
(Table 1) . These patients form the study group of the present
analysis .
Patient management . After providing informed consent,
patients were treated with heparin (a 5,000 IU bolus injec-
tion, followed by 1,000lU/h intravenously), aspirin (250 mg)
and single chain n-PA (Alteplase, 100 mg over 3 h) . Coro-
nary angiography was performed as soon as possible in all
patients who had been randomized to the invasive strategy .
Angioplasty was to be
attempted, provided that there was a
luminal diameter stenosis of >60% in the infarct-related
coronary artery, In case of complete occlusion. mechanical
perforation had to be performed .
Aspirin (75 to 125 mg) was continued on alternate days
until hospital discharge. Heparin could be replaced by oral
anticoagulant agents after 3 days, provided that tall setico-
agulatien was maintained until cardiac catheterizatiu n,
Electrocardiographic analysts
. Infarct localization was
determined from the admission ECG by the core laboratory .
It was judged anterior if ST segment elevation was present in
leads V, to V, and inferior if ST segment elevation occurred
in leads II, I11 and aVF . In case of ST segment elevation in
leads 1, aVL, V, and Va , infarct localization was deemed
anterior unless ST segment elevation was also present in
leads It,111 or aVF or ST depression was present in leads V 1
to V„ in which cases the localization was inferior . The ST
segment shift was measured at the I point .
Cnr mary arteriograpgy and ventrica ography. Coronary
arteriography and left ventriculography were performed 10
to 22 days after treatment allocation . To enhance compara-
bility between the two groups, each clinic was required to
perform angiography within a preselected time window of i0
to 14, 12 to 16, 14 to I8, 16 to 20 or Iii to 22 days after
allocation
. Seta-adrenergic blocking agents, calcium channel
antagonists and nitrates were slopped the night before angi-
ography
. All angiogmms were assessed by members of the
Angiography Assessment Group . Perfusion of the infarct-
related vessel was assessed using the Thrombolysis in Myo .
cardial Infarction (TlMI) perfusion score (3-5).
Left ventriealography was performed with a 0.5 to I mllkg
nonionic contrast injection at a flow of`6 to 20 mils in the 30'
right anterior oblique projection . End-systolic and end-
diastolic contours were digitized . Left ventricular volumes
in the right anterior oblique projection were calculated
accurdinp to Simpson s rule after calibration with a phantom
of known volume filmed after ventriculography and were
indexed fur body surface area . No corrections for trabeculae
and papillary muscles were applied . All analyses were
performed at the core laboratory for quantitative angiogra .
phy without knowledge of treatment allocation .
Regional Left Ventricular Wall Motion Analysis
Regional wall motion was analyzed according to : li the
"regional contribution to ejection fraction method," which
assesses wall motion along experimentally determined and
validated vectors
(2,6) and detects small differences in
regional wall motion (2)
;
2) the "centerline method," which
assesses fractional shortening in 100 chords perpendicular to
a centerline between the end-dinstolic and end-systolic cow
lours(7!9) ; and 3) the "radial axes method," which assesses
fractional shortening in 300 radii from the center of mass of
the end-diastolic contour (10) . In none of the methods were
translational or rotational corrections made. Adescription of
each model is given in Figures
I to 5
.
The extent of hypokineala ("all motion in
the hdarct
territory). This was assessed by quantitative regional wall
motion with all three models. In the regional contribution to
ejection fraction method, it was the number
of
segments with
abnormal regional contribution to ejection fraction (below
the 10th percentile of a group of 31 normal individuals) per
patient . In the centerline method, it was the number of
contiguous chords in which the shortening fraction differed
by >1 standard deviation from the mean shortening fraction
in a group of normal individuals (so-called circumferential
extent of wall motion abnormality). In the radial axes
method,
it was the percent of radii in which the shortening
fraction differed by >2 standard deviations from the mean
normal shortening fraction in a group of normal individuals
(so-called hypokinerie circumference).
The sererRy of byy okfnesia . This was assessed with the
regional contribution to ejection fraction method as the mean
regional contribution to ejection fraction per abnormal seg-
ment (%) and was calculated by dividing the sum of regional
contributions below the 10th percentile of normal by the
number of abnormal regions (11).
Aneioyapht at 10 to 22 Days
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In the centerline method . hypokinesia was defined as
maximally abnormally contracting 50% (expressed in stan-
dard deviation(chord), computed as follows . The difference
between shortening fraction of each chord and mean short-
ening fraction of the corresponding chord in a group of
normal individuals was divided by I standard deviation of
normal for each chord in the hypokinetic area . This differ-
ence divided by I standard deviation of normal is called
"smndardized motion" of a chord . The hypokinetic area
was defined as a set of contiguous chords chosen in such a
way that half the number of chords in the infarct territory are
included and that the mean standardized motion in that set of
chords is most abnormal . This mean standardized motion in
the hypokinetic area is called maximally abnormally con-
tracting 50% (7-9).
In the radio( axes method, the severity of hypokinesia
was given by the contribution to the global ejection fraction
by the sector of radii with wall motion abnormality >2
standard deviations of normal wall motion (called regional
ejection fraction in the infarct territory) .
Hyperkinesia. Similarly, the extent and seventy of hy-
perkinesia (wall motion abnormality in the contralateral
area) were determined with the regional contribution to
ejection fraction method as the number of segments with
abnormal regional contnbotion to ejection fraction and the
mean regional contribution to ejection fraction per abnormal
segment 1%) . Abnormal segments were delined as those with
regional contributions exceeding the 90th percentile of nor-
mal. For the centerline method, only the severity of hyper -
m
la
4
17
Figure l
. RJionat contaibtatien to ejection fraction (CREFI method
of regional wall motion analysis . A. End-diastolic left ventricular
endocardiel contour in 30' right anterior oblique left ventncutogram .
The ''-0 coordmales along which left ventricular wall motion occurs
are suwia,ui used. & The volume of each slice in the end-diastolic
I olumr: is caculated from the radius of the slice IR) and 1(20th of the
left eemriculat long-axis length ILI as;
S' - IC0 c n x R' x L
The slices er segments are numhered from 1 to in for the anterior
will cod from 11 to 20 for the inferoposterior wall . C, Similarly. the
volume of each slice in the erd-diastolic volume (ED) is calculated .
The regional contribution to global ejection fraction is determined
I Erd-Jiasralie - Ernl-nrOot c [ES]I Slice volume
ao9.
Global ,rdaiaelore volume
D, An example of a plot of regional centebutien to ejection fraction
in which the values for regional contribution to ejection fraction (x
axis) for all 20 segments (y axial are given . The shaded tyres
represzct t'he loth and 90th percentiles of the regional contribution
to ejection fraction for each segment m normal individuals . Repro-
duced from betrays or al . ;2). with permission .
kinesia was calculated (7) as maximally abnormally contract-
ing 50% (standard devialiontchord) .
Luealixaliun of iWigrd and tlmninfarc1 lerrjlmries, In
the
centerline method, these were defined by the angiographi-
cally assessed infarct-related vessel and the number of
diseased curonery arteries (7-9) . In the regional contribution
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19
2
1B
3
17
4
16
a
5
15
10
6
14
7
13
B
12
9
11
10
14
	
ARNOLD ET AL
.
JACC Val. 11 . No . I
IMMCL ATE ANGIOPLASTY FOR MYOCARDIAL INFARCTION
January 1SJI .11-21
to ejection fraction method and the radial ayes method,
regions of hypokinesia were nut defined by coronary anat-
omy, but considered in all segments, except for the latter
method if two hypokinetic regions separated by -25 radii
were found . In that case, selection of the appropriate region
was made on the basis of infarct localization on the qualify-
ing ECG.
Enzymatic infarct
size
.
Cumulative release of plasma
alpha-hydroxybutyrate dehydrogenose was determined cen-
trally in the core laboratory for enzyme determinations from
ACUTE INFARCTION
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Figure L . Centerline method of regional
C wall motion analysis . A, End-diastolic and
e.nd-sysm!
:e left venrdeuia, to at Crdial
contours with ti -ipmer-consimctcd
centerline in between . s, Motion Is mea-
sured slang 100 chords constructed per-
pendicelar to the centerline . C, Motion at
each chord divided by the enddiaslottc
perimeter yields a shortening fraction,
Merlon along each chord is plated for the
patient. In addition, the mean motion (t I
standard deviation) In the group of 31
normal individuals is plotted for compari-
son, I), Standardized motion, The differ-
ence between the shortening fraction of a
chum and the mean shortening fraction of
that chord number in a group of nonnat
individuals was divided by the standard
deviation of the mean shortening fraction
of that chord number in the group of
normal individuals . Reproduced from
Shehan el al ., with permission of the
American Heart Association, Inc
.
Mars 3. Radial axes method
. The cent,at axis (0 to 11111°) is
determined by the center of mass of the end-diastolic contour and
the junction of the mural and aortic valves . The percent radial
shortening of approximately 300 radii (shaded ma) is calculated as ;
(Frddiaslclio ndies - sad-systole radius)
Enddiectcic svdiur
and plotted together with the man (t 2suindairdideviadars , SDI) of
a group of 31 nomad (Norm) subjects (three mild iians). The sector
in which radial shortening was less than the mean normal radial
shortening minus 2 standard deviations is called the hypokinetic
region tin this example, from 93 to 233'.
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serial plasma samples at 12, 24, 36
.48 and 72_'a after treatment
onset
. Details have been published elsewhere 11 .12 ; .
Data {nafysis
9aseline risk assessment Because more patients in the
invasive treatment group did not undergo cardiac catheter-
ization because of death or cardiac contraindications than in
the noninvasive group
( I able 1), unequal distribution cihigh
risk patients among the two treatment groups in the present
analysis was likely to influence the measured treatment
effect of the invasive strategy- Therefore, individual baseline
risk was assessed .
Baseline risk
assrssnteni ruostnted of ifire, sleCal . First .
the relation between baseline characteristics and the number
of segments with regional contribution to eicction fraction
ARNOLD ET .AL.
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Figure 4. Mean regional contribution to global ejection fraction
ICREFI in 20 segments of the letl ventriculogram in patients with
anterior t M and diaphragmatic rRl infarct localization . The harehed
area represents the normal 10r, to 90% range . Patients allocated to
the noninvasive strategy are represented by the dated lice : patients
allocated to in-me treatment by the solid line . Analysis was done
w,th the re¢ponal contnbuion to ejection fraction method
.
below the 10th percentile of normal was assessed with
muhivarlale linear regression analysis. Only baseline char-
acterislics known to he related to left ventricular function
111) or outcome or coronary angioplasty (14). or both, were
consl(ierod . 1) age, 2) gender, 31 history of previous infarc-
tion . 41 history of angina >4 weeks
. 5) sum of ST segment
elzu ,, n on the EC(i, 6) infarct localization, ?) hemody-
naau, stains belure thrombelylic treatment, and 8) delay
1 6
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Figare 5. Mean regional contribution to
global ejection fraction
(CREF) in 20 segments of the left veotnicalogram in patients with a
patent infarct-related vessel on angiography between days Ill and 22
(Thromholysis in Myocardial Infarction perfusion grade 2 or 3) and
without reinfaretiaa . Anterior (A) and diaphragmatic (5) infarct
localizahrnl . The hatched a m represents the normal 1e to 90%
range. Patients allocated to the noninvasive strategy are represented
by the dotted tine; patients allocated to invasive Treatment by the
sow tine.
from symptom onset to start of rt-PA infusion . Details ofihe
multivariate linear regression analysis are given in the Ap-
pendix . Second, the number of segments with regional
contribution to ejection fraction below the 10th percentile of
normal was calculated from this multivariate model in each
patient by setting the indicator variable for treatment allo-
cation to values indicating noninvasive treatment . Finally,
patients were subdivided in three equally sized groups of
low, medium and high baseline risk .
Subgroup analysis. The number of segments with re-
gional contribution to ejection fraction below the 10th per-
centile of normal was assessed in both treatment groups
stratified according to variables available before treatment
allocation
. The regional contribution to ejection fraction
method was chosen for the baseline risk assessment and
subgroup analysis because it has the advantage that it is
applicable without ltnowledge of the infarct-related vessel
.
The method is therefore available in a ilidher proportion of
patients . Furthermore, the method is validated in both
animal and patient studies 12,6) . The multivariate ntethdddl-
ago is described in the Appendix .
Adjustment for imbelmices in baseline risk. Differences
between both treatment groups for all variables of regional
JACC Vol. 1' . No .
Jannnrt 171] .11-'01
Table 2 . Baseline Cheracleriheirs Related to Left Ventricular Llectlon I racoon a Hospital Discharge
wall motion were adjusted for imbalunces in baseline risk by
multivariate linear regression analysis
. With this technique .
the treatment effect of immediate coronary angioplasty' aG-
jusred for other determinants of the outcome variably is
provided by the coefficient of the indicator variable for
treatment allocation ,see Appendlxl (15).
Results
The regional contribution to ejection traction method
could be assessed in all 291 patient, with an analyzable left
ventriculogram between days III and 22 . Determination of
the maximally abnormally contracting 50r/r ,cen(erline
method) was not possible tot 28 patients in the noninvasive
and 9 patients in the invasjve treatment group because of
uncertainty about which vessel was infarct-related,
engine characteristics related to regional left ventricular
wall motion (Talk 21 . Anterior infarct localization and pre-
virus myocardial infarction were strong predictors of poor
tegional left ventricular lunclion . Other contributors to
reduced wall motion were the sum of ST segment elevation
and delay to start of ri-PA therapy_ Linear regression
coefcienis (Table 3) indicate the contribution of each deter-
minant of baseline risk- Intercept and coeitneats as ob-
served in thin trial were very Similar to those in 577 other
patients entered in the rt-PAlplaceho trial, which is con-
.AayOLV ET AL
.
	
1 7
MV Pill ,15 4 11InILAST' FOR b1YOCAROIAL INFARCEON
Number of rentneis With regnrtal conlnbeh00 Io eject an 1100,00 below the 10Th pace ntdc of normal m each category Imorn and stondard dexial or In
mrnnthesmt .theMar'lane.Slmplctofallba-uire :hataarorlikslaaOladldda4lnoirenl ureiaroeotinlae5051950nsk,curelibeliilhepredlctednumrer
of,mnonis with
ale-al
regional conirlhunor in ejeetmn fraction . with linear renTs one an:41 .1, from the above bnsehne charnelensrie5 inabb Ier Orinseri1Y
treamern) I r hfelhnds] . Nn, of amnormal CRFF; - number of segment, nits rtchm : . c,,,r hmlon to ejisarrt emotion below the lies pcreemile of .-at
ducted by The same study group using similar mellmdolegy
in 23 other hospitals (12) . This supports the validity of the
baseline risk model used in the present analysis .
Baseline risk assessment w--full., separated 4igh and
(on' rink patients . The number of segments with abnormal
regional contribution to ejection fraction in the noninvasive
treatment group was twice as high in the high risk group
than in the low risk group (Table 21 . Compared with the
noninvasive treatment group, there was an excess of high
risk patients with an assessable left ventriculogram in
the invasive treatment group (40 .8% versus 34 .2% . respec-
lively) . As a consequence, any true difference in regional
wall motion between treatment groups cannot be assessed
without adjustment for this unequal distribution of baseline
risk .
Left ventricular function (Table 4) . After such adjust-
ment . ventncular function was similar in the two treatment
group}, both for global and regional wall motion . Confidence
intervals Or the differences were nearly symmetrically
around zeroi indicating that no real difference in treatment
effect between the two treatment strategies was present
.
Subgroup analysis
. None of the patient subsets defined
by the baseline characteristics mentioned in the Methods
section benefited from immediate angioplasty as determined
by either univariate iTable 2) or multivariate analysis .
No. of Plients With CIO-1 U' No, of Abnormal CREFs
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Table 3
. MuIIivariale Linear Regression Analysis to Predict the Number of Segments With
Abnormal Regional Contribution to Ejection Fraction
Occlusion of infarct-related vessel and reinfarctkm. Pa-
tency of the infarct-related vessel could not he assessed in 4
of the 149 patients in the noninvasive treatment group and in
I of the 142 patients in the invasive treatment group with
analyzable left ventriculograms
. An occluded infarct-related
vessel at angiography between days 10 and 22 or reinfare-
tiun, or both, occurred more often in the invasive treatment
group 125 of 141 patients) than in the noninvasive treatment
group (19 of 145 patients) .
In parienms Wilt a patent injarer-refeired vessel or angiog-
mphy between days
10 sad 22 and withonl reirddrction,
global left ventricular ejection fraction was 1 .9 percentage
points better in the invasive strategy group (Table 5) . This
was merely due to a smaller area of hypokinesia . The
severity of hypokinesia and hypekinesia was similar in both
treatment groups . Findings for all three models of regional
wall motion analysis were consistent . In this subset
of
patients, enzymatic infarct size was similar in both treatment
groups (median olpha-hydrovybutyrate dehydrogcnasc
plasma activity 615 U/liter [90% confidence range 46 to
1,8921 in 126 patients in
the noninvasive treatment group and
660 UAiter (90% range 115 to
1,5761 in 116 patients in the
invasive treatment group) . The same was found after adjust-
In the tree
.odd,
.11 291 patients were included . A wand model wee devnloped in 242 patients with a patent
infarct-refaled vessel al aagiogrephy between days 10 end 22 and without reinfardion . To test the reproducibility, a
similar multivariate model was developed in an Independent group of 577 patients with analyzable left sentruuhr-
grmns from the n-PA/ptcebo trial of the European Coapemtive Study Group (12). Coefficients for treatment
allocation represenl the treatment egerl of imrnedieu angloplasty in the first two modelsand theageet oftreaement
with n-PA in the third model . The number elabnormal segments in an individual patent is determined by adding up
intercept and all relevant coefficients . For example. a patient without pmaus infareoon, >2 mV ST elevation,
inferior infarction . Kiliipclass 1, treated with a-PA within 2 hand allocated to invasive serategy has5
.6+ 1 .8 -0
.1
= T
.)
segments with ahnornd contribution to ejection fraction . The mesa patient after noninwave therapy 955 7 .4
abnormal segments
. Values are linear regression coeftcieots with their standard error in parentheses
IACC Val. 17, Na .
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Intent for unequal baseline risk (infarct Localization, time to
rt-PA infusion and ST segment elevation) with linear regres-
sion analysis .
Discussion
Despite theombolytic therapy with
in-PA,
the infarct-
related vessel remains occluded in approximately 25% of
patients (1,4,16). Furthermore, some patients have a hemo-
dynamically significant sleuosis after thrumbulysis. Immedi-
ate coronary angioplasty has been proposed to rec snalize the
remaining occluded vessels and improve blood flow in
patients with severe residual stenasis .
Recovery of left ventricularfunction and the incidence of
reocclusion were reported to be related to the degree of
residual stenosis after ihrombolysis (11-19) and the results of
small randomized trials (20
.21) assessing immediate angio-
plasty with and without intracoronary streptokinase sug-
gested that recovery of left ventricular function might he
improved by angioplasty . However, the present larger ran-
domized trial of the European Cooperative Study Group
failed to confirm this . Other investigators also reported lack
Model
All Patients
(n = 291)
PetentMVNe
Reinfarctiae
in = 2421
n-PwPlacebo
Tdal
In = 577)
Intercept 5.6 5.8 6 .5
History of infuatlon
No
Yen 2.5 to so 2.6 to 91 2.4 {0.61
Sanl ST lrVI
]A111 .51 1 .7(0 .51 1610.3)
Art- infarct braliulion
Na
Yes t,10 .4) 3 .6104) 3 .1 0.3)
Delay to rrPA Chi
Q
2-3 LU 10 .5) 1110 .61 0610.4)
z3 1 .5(0.51 1.31061 1 .1111 .4)
AIIxaUAt ---c M.'sy
No
Yes -0.110.41 -0 .410,4)
Allocaion to n-PA
No
Yes -n5 (0.31
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Table 4 'Creatment Effect of Immediate Coronary Angioplasty Before and After Adjustment for Unequal Baseline Risk in All
291 Patients
'Far adiusled difemnce . The regional cuniributiun to ejection fraaiun ICREFI,
-wedin
and radial axes erelhuds were used le determine :he eamnt of
liypokkak in 291, 289 and 291 padentn, rn,pectively, severity of Ilypokhresia w .awed in 289. 255 and 2&t pa[iems, rnnpec[isely . The sa'erily f
hyperkhlesm wasawecsed in 189 patients with the regional contribution m ejection friction mmhud
l
In 102 patients . nuhypakinesia was present wish Lids melleodl
and in 215 patients with the centerline method. The extent of hyperkinesia was assessed In 291 patients . Values are mean and standard devialiun tin Irarenlbeeesl .
LV = left
ventricular;
LVEF = left venuicular eecliun fraction,
of benefit of immediate (4,16) or delayed (18 to 48 h)
angioplasty in patients treated with a-PA.
Baseline comparability . There was an excess in baseline
risk in the invasive treatment group in the present analysis .
This could not be explained by the fact that patient, without
predischarge left ventriculography were excluded in the
present analysis because lack of left ventriculography was
related to poor left ventricular function and the fact that
more patients in the invasive treatment group did not un-
dergo left ventriculography (Table I) . The explanation is that
randomization did not yield groups of idenhcal baseline risk .
Although randomization is the best way of achieving patient
Table 3, Treatment Effect of Immediate Coronary Angioplasty Before and After Adjustment for Unequal Baseline Risk in 242 Patients
With a Patent Infarcl•Related Vessel at
.Angiography Between Days 10 and 22I'tlMl perfusion grade 2 or 33 and Without Reinfarctien
Before Angiogtaphy
MeanlSDI Dif nee msa.a : - nnim .1 vet
Vullzingtheregiaodc:ntribatlon1.erectionfraelion1CRFR,centenhncandndnd
:rnre r,,dsasinTable4,thenambersafpatientsrespectivelyevalaat.d
exlem of hhpokinesia - 7.42 . 234 and 242 . ,e0enty of hyper),-- =
•_4•_ , 315 and 217'. .evrrity of hyperkiewm = If2 with the reerond .safhutiOn m
ejeoE_n fraction method ;90 wish no hyperkiercial and 214 with the centerline method
. Abbreviations as in Table 4 .
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0 .6138; 0713.91 0 .1 301 .33
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CREF 2 .112 .31 2-010-0.1 0 .0 -05005
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gruups with identical baseline risk . it is not always success-
ful . especially in small and medium-surd Irialn (221.
Multivariate linear regression analysis provides an esti-
mation of relative efficacy of treatment strategics, adjusted
for imbalances in baseline risk. After adjustment . n o benefit
of immediate angioplasty was found .
Occlusion of infarct-related vessel and reinfarction
. In the
present trial, immediate angioplasty was associated more
frequently with an occluded infarct-related vessel and rein •
farcticn during the hospital stay, which might have abolished
a benefit from immediate angioplasty . In fact, a trend toward
improved regional wall motion was observed in those pa-
tients with a patent infarct-related vessel and without recur-
rent infarction at the time of hospital discharge . The magni-
tude of treatment a .ect of immediate angioplasty let these
patients was of the same order of magnitude as that found for
thrombolytic therapy with rt-PA in comparison with placebo
(Table 3) . This suggests that immediate angioplasty may be
beneficial if the complications of angioplasty - sthal is, reoc-
clusion and reinfarction) can be prevented .
Better left ventricular function after immediate coronary
angioplasty in patients without reocclusion or reinfarction .
or both, may be explained by further limitation of infarct size
and by enhancement or acceleration of left ventricular
recovery . The fact that enzymatic infarct size was not
reduced favors the latter explanation . In addition, this is in
agreement with the observation that recovery of left ventric-
ular function is related to residual ste nosis after thrombolytic
therapy (17) .
One might argue that excluding patients in whom infarct-
related vessel potency could not be assessed night have
influenced the effect of immediate angioplasty in patients
with a patent infarct-related vessel and without reinfarction .
However, the same results were obtained if these patients
were included in the analysis .
The lack vfbenefrr of the inou.ctee strategy in the present
trial may also be partly due to ue,dden and complete reper-
fasion during angioplasty . There is evidence from animal
experiments that recovery of left ventricular function is
accelerated after gradual tcpedusiott lover 2 h) in compari-
son with recovery after sudden reperfusion . The underlying
mechanism is unknown . but the no-reflow phenomenon and
increased calcium influx with contraction band necrosis may
contribute (23)
.
Thus, a certain degree of residual stenosis
after thramholysis may help protect myocardium against
repetfusion damage .' this would favor an approach of imme-
diate thrombolytic recanalization or mechanical recanaliza-
lion with a guidewire, followed by coronary angioplasty after
a few hours. This regimen requires further study .
Patient selection . In the present t rial. no patient subset
benefited from coronary angioplasty; angioplasty was at-
tempted in most patients (92%), including patients with an
occluded infarct-related vessel . Initial experience with im-
mediate coronary angioplasty in patients with an occluded
infarct-related vessel at 90 min after start of thramholysis
with rt-PA ("rescue angioplasty") was not favorable (16),
but promising results were obtained when rt-PA was com-
bined with urokinase 124)_ The concept of rescue angioplasty
deserves further study in connection with a treatment regi-
men for the prevention of reocclusion or reinfarction . This is
especially true if patients with persistent occlusion (failed
thramholysis) can be recognized ncrninvnsively . At present,
angioplasty and coronary bypass surgery should be reserved
for treatment of recurrent postinfa
.-etion isehemio nor re-
sponding to medical treatment . The role of thallium myocar-
dial perfusion scintigraphy in the selection of patients for
revascularizatinn procedures remains unknown .
Cuncludon. No benefit of an invasive strategy of imme-
diate coronary angioplasty in addition to rl-PA, heparin and
aspirin could be documented when compared with a nonin-
vasive strategy with rt-PA, heparin and aspirin alone . Nev-
ertheless, a trend toward benefit of immediate angioplasty
was found in selected patients with a patent predischarge
infarct-related vessel and without reinfarction. This suggests
that reocclusion and
reinfarction are responsible for the lack
rf h^neflt F7, -n i-mediate coronary angioplasty after throm-
bolytic- therapy for acute myocardial infarction . At present,
an invasive strategy with immediate angiography and angio-
plasty cannot be recommended, but angioplasty in selected
patients (for example, those with failed thrombolysis) war-
rants further investigation provided that reocclusion and
reinfarction can be prevented .
Appendix
Linear regression analysis . This was performed (BMDP statistical
software package, program 1R and 2R) to assess the relation
between the variables mentioned in the Methods section (indepen-
dent variables = X,) and each variable of left ventricular function
(dependent variable = Y)
:
Y = A 1 1, n . xr
Independent and dependent variables . Indicator variables were
defined by assigning zero To patients in whom an event or charac-
te nslic was absent and I in those in whom an event or characteristic
was prcsen I . Continuum variables were not used directly . For these
variables, patients were categorized in Three equally sized sub-
groups according to patient values for that variable, The category
with the lowest value for the variable of wall motion under study
was chosen as the reference group. For the second and third
subgroups, indicator variables were designed : I in case a patient
belonged to that subgroup, zero if not . Thus, patients in the
reference group were characterized by zero for the design variable
for the second and third subgroup
.
Design of the linear regression madek . For the baseline risk
model, all indicator variables representing the baseline characteris-
tics mentioned in the Methods section were simultaneously entered
in the model . Only indicator variables with coefficients of p s 0
.1
were retained in subsequent models unless a product term of that
term with another term had to be included in the model . In that case .
the indicator variable was forced into the model . The same applied
for the indicator variable of treatment allocation .
Fortune varinhlr of regional Mall motion, the seine independent
IACC Vol . 17. No . I
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variables as used for the o.,line ri	nt were ant J in l
model to adjust for unbalanced h se, ne risk of rag ansl wall a
'
urn .
To assess the contributions of the carious determinanr in natS
treatment groups separately. product terms- Indicator variuhle
for determinant under study multiplied by the rat Guar o :n a le of
treatment allocation) were tested La the model 1251
Interpretation of results of linear repression model . Becau,z ill
independent variables ar zeroll variables, the coefficient, IB,I
reflect the difference DIFI in the number of segments with logical
contribution to ejection fwcrion helow 111 I01h perccnlllc of normal
between a patient with charctensle X, and a pat eat wilhou: that
characteristic, all other determinants of rugiaral call motion being
equal. The 95% confidence limits for this dilerenca may he calcu
laced from the standard error iSE,l of
the coefficient
l :
DIF = 196 •ISE' .
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